PB2012: DESCRIBING TREATMENT PATTERNS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME ACCORDING TO IPSS-R RISK CATEGORY

• Sorcha Corry,
• Arushi Bamrara,
• Núria Lara,
• Daniel Cuadras,
• Federica Centorrino,
• Ricardo Viana

Affiliations

Sorcha Corry

1 Novartis Pharmaceuticals & Novartis Global Services Center, Dublin, Ireland

Arushi Bamrara

2 Novartis Healthcare Pvt. Ltd, Hyderabad, Telangana, India

Núria Lara

3 IQVIA, Barcelona, Spain

Daniel Cuadras

3 IQVIA, Barcelona, Spain

Federica Centorrino

3 IQVIA, Barcelona, Spain

Ricardo Viana

4 Novartis Pharma AG, Basel, Switzerland